Nattokinase for Hypertension
The objective of this study was to examine the effects of nattokinase supplementation on blood pressure in subjects with pre-hypertension or stage 1 hypertension. In a randomized, double-blind, placebo-controlled trial, 86 participants ranging from 20 to 80 years of age with an initial untreated systolic blood pressure (SBP) of 130 to 159 mmHg received nattokinase (2,000 FU/capsule) or a placebo capsule for 8 weeks. Seventy-three subjects completed the protocol. Compared with the control group, the net changes in SBP and diastolic blood pressure (DBP) were -5.55 mmHg (95% confidence interval [CI], -10.5 to -0.57 mmHg; p<0.05) and -2.84 mmHg (CI, -5.33 to -0.33 mmHg; p<0.05), respectively, after the 8-week intervention. The corresponding net change in renin activity was -1.17 ng/mL/h for the nattokinase group compared with the control group (p<0.05). In conclusion, nattokinase supplementation resulted in a reduction in SBP and DBP. These findings suggest that increased intake of nattokinase may play an important role in preventing and treating hypertension.
Comment: Nattokinase is a fibrinolytic enzyme found in natto (fermented soy beans). The results of this study indicate that nattokinase is an effective treatment for mild hypertension. While nattokinase treatment decreased plasma rennin activity to some extent, it had no effect on angiotensin-converting enzyme activity. Therefore the mechanism of action of nattokinase as an hypertensive agent is not clear. Although it is a fibrinolytic enzyme, nattokinase does not appear to cause abnormal bleeding. It is no known, however, whether it is safe to administer nattokinase to people taking anticoagulant or platelet inhibiting medications.
Kim JY, Gum SN, Paik JK, Lim HH, Kim KC, Effects of nattokinase on blood pressure: a randomized, controlled trial. Ogasawara K, Inoue K, Park S, Jang Y, Lee JH. Hypertens Res. 2008 Aug;31(8):1583-8. View Abstract
Related articles:
- Vitamin C and Hypertension in Young Women
- Prevention of Influenza Episodes With Colostrum Compared With Vaccination in Healthy and High-Risk Cardiovascular Subjects
Keywords:blood pressure, enzyme, hypertension, nattokinase
If you found this post interesting, please share it, leave a comment or subscribe to the RSS feed and get future posts delivered to your feed reader.
Leave Comment
You can ask technical questions, be as supportive, critical or controversial as you like, but please don't get personal or offensive, and do keep it brief. Your comments will be published only after verification.
The immune system is prone to the same grave misfortunes as any defense system handling weapons: collateral damage that comes with the destruction of the enemy on one’s own territory and friendly fire due to mistaken identity. Whereas the collateral damage is the price we pay for clearance of infections, autoimmunity is a pathological process. Nevertheless, the effector mechanisms involved in both processes are the same. Whether environment can be a cause, a trigger or an amplifier of an autoimmune disease are questions that are being intensively investigated.
